A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects.

Trial Profile

A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs VGX 1027 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors VGX Pharmaceuticals
  • Most Recent Events

    • 01 Mar 2016 Results from this and the other phase I study, published in the Clinical Pharmacology in Drug Development.
    • 08 Apr 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 27 Mar 2009 Status changed from active, no longer recruiting to completed, as reported in a medeia release from VGX Pharmaceuticals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top